Response to Patoulias et al. letter regarding article “Twelve weeks of treatment with empagliflozin in patients with heart failure and reduced ejection fraction: A double-blinded, randomized, and placebo-controlled trial”

Publication date: June 2021Source: American Heart Journal, Volume 236Author(s): Jesper Jensen, Massar Omar, Jacob Eifer Møller, Morten Schou
Source: American Heart Journal - Category: Cardiology Source Type: research